TEM · Insider Trading
Tempus AI, Inc. Class A Common Stock
Every open-market purchase and sale reported by TEM officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-29 | Thomas Edward Schoenherr | CEO, Diagnostics | Sell | −10,281 | −$873.88K |
| 2026-09-24 | Eric P Lefkofsky | CEO and Chairman | Sell | −250,000 | −$19.37M |
| 2026-09-18 | Andrew Polovin | EVP, Chief Legal Officer | Sell | −2,951 | −$221.32K |
| 2026-09-18 | Ryan M Bartolucci | Chief Accounting Officer | Sell | −7,062 | −$529.65K |
| 2026-09-18 | Ryan Fukushima | CEO, Data | Sell | −700 | −$49.00K |
| 2026-09-18 | Eric P Lefkofsky | CEO and Chairman | Sell | −200,000 | −$16.11M |
| 2026-09-03 | David R Epstein | Director | Sell | −250 | −$16.39K |
| 2026-09-03 | Jennifer A Doudna | Director | Sell | −676 | −$44.31K |
| 2026-09-03 | Ryan Fukushima | CEO, Data | Sell | −30,846 | −$1.93M |
| 2026-09-01 | Nadja West | Director | Sell | −3,000 | −$207.00K |
| 2026-08-27 | Eric P Lefkofsky | CEO and Chairman | Sell | −11,848 | −$827.86K |
| 2026-08-27 | Eric P Lefkofsky | CEO and Chairman | Sell | −238,152 | −$16.29M |
| 2026-08-25 | Thomas Edward Schoenherr | CEO, Diagnostics | Sell | +2,694 | +$188.58K |
| 2026-08-25 | Ryan Fukushima | CEO, Data | Sell | −14,286 | −$1.00M |
| 2026-08-20 | Ryan M Bartolucci | Chief Accounting Officer | Sell | −6,175 | −$306.34K |
| 2026-08-20 | Andrew Polovin | EVP, Chief Legal Officer | Sell | −30,075 | −$1.54M |
| 2026-08-20 | Ryan Fukushima | CEO, Data | Sell | −41,095 | −$2.04M |
| 2026-08-20 | Thomas Edward Schoenherr | CEO, Diagnostics | Sell | −17,314 | −$929.99K |
| 2026-08-20 | Eric P Lefkofsky | CEO and Chairman | Sell | −132,591 | −$6.58M |
| 2026-08-20 | James William Rogers | Chief Financial Officer | Sell | −48,842 | −$2.70M |
| 2026-08-18 | Nadja West | Director | Sell | −3,000 | −$161.70K |
| 2026-08-14 | Ryan Fukushima | CEO, Data | G | −62,239 | — |
| 2026-08-11 | Ryan Fukushima | CEO, Data | Sell | −20,000 | −$1.00M |
| 2026-08-05 | David R Epstein | Director | Sell | −370 | −$16.06K |
| 2026-08-05 | Ryan Fukushima | CEO, Data | Sell | −23,818 | −$1.10M |
| 2026-07-31 | James William Rogers | Chief Financial Officer | A | +40,000 | — |
| 2026-07-31 | Andrew Polovin | EVP, Chief Legal Officer | A | +40,000 | — |
| 2026-07-30 | Eric P Lefkofsky | CEO and Chairman | Sell | −250,000 | −$10.51M |
| 2026-07-10 | Ryan Fukushima | CEO, Data | Sell | −33,284 | −$1.91M |
| 2026-07-08 | Ryan Fukushima | CEO, Data | Sell | −10,000 | −$600.00K |
| 2026-07-01 | Eric P Lefkofsky | CEO and Chairman | Sell | −166,250 | −$9.56M |
| 2026-06-29 | James William Rogers | Chief Financial Officer | Sell | −11,529 | −$634.10K |
| 2026-06-29 | Jennifer A Doudna | Director | Sell | −2,673 | −$147.01K |
| 2026-06-03 | David R Epstein | Director | Sell | −250 | −$12.35K |
| 2026-05-29 | Eric P Lefkofsky | CEO and Chairman | Sell | −166,250 | −$7.76M |
| 2026-05-26 | Peter J Barris | Director | A | +5,913 | — |
| 2026-05-26 | Jennifer A Doudna | Director | A | +5,913 | — |
| 2026-05-26 | David R Epstein | Director | A | +5,913 | — |
| 2026-05-26 | Wayne A.I. Frederick | Director | A | +5,913 | — |
| 2026-05-26 | Scott Gottlieb | Director | A | +5,913 | — |
| 2026-05-26 | Theodore Leonsis | Director | A | +5,913 | — |
| 2026-05-26 | Nadja West | Director | A | +5,913 | — |
| 2026-05-26 | Eric D Belcher | Director | A | +5,913 | — |
| 2026-05-21 | Ryan M Bartolucci | Chief Accounting Officer | Sell | −4,116 | −$181.39K |
| 2026-05-21 | Ryan Fukushima | CEO, Data | Sell | −13,550 | −$597.15K |
| 2026-05-21 | Eric P Lefkofsky | CEO and Chairman | Sell | −22,335 | −$984.30K |
| 2026-05-21 | Andrew Polovin | EVP, Chief Legal Officer | Sell | −8,703 | −$383.54K |
| 2026-05-21 | James William Rogers | Chief Financial Officer | Sell | −10,853 | −$478.29K |
| 2026-05-21 | Thomas Edward Schoenherr | CEO, Diagnostics | Sell | −1,580 | −$69.63K |
| 2026-05-15 | Ryan Fukushima | CEO, Data | G | −100,000 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Blue Media, LLC | 10%+ Owner | 31,385,066 | $2.02B |
| Eric P Lefkofsky | CEO and Chairman | 17,066,240 | $1.10B |
| Bradley A Keywell | 10%+ Owner | 16,002,638 | $1.03B |
| Red Sky Ventures LLC | 10%+ Owner | 15,360,249 | $988.28M |
| Ryan Fukushima | CEO, Data | 578,337 | $37.21M |
| Andrew Polovin | EVP, Chief Legal Officer | 135,189 | $8.70M |
| James William Rogers | Chief Financial Officer | 132,337 | $8.51M |
| Peter J Barris | Director | 121,424 | $7.81M |
| Theodore Leonsis | Director | 88,180 | $5.67M |
| Erik Phelps | EVP, Chief Admin. Officer | 85,466 | $5.50M |
| Thomas Edward Schoenherr | CEO, Diagnostics | 76,740 | $4.94M |
| Ryan M Bartolucci | Chief Accounting Officer | 60,804 | $3.91M |
| Scott Gottlieb | Director | 40,749 | $2.62M |
| Eric D Belcher | Director | 35,457 | $2.28M |
| Nadja West | Director | 31,981 | $2.06M |
| David R Epstein | Director | 30,844 | $1.98M |
| Wayne A.I. Frederick | Director | 30,749 | $1.98M |
| Jennifer A Doudna | Director | 25,266 | $1.63M |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the TEM quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.